Specialty pharmaceutical and personal care company
| Website | http://www.ccs-se.com |
| Revenue | $360.9 million |
| Employees | 61 (30 on RocketReach) |
| Technologies | |
| Industry | Pharmaceutical Manufacturing, Drug Manufacturing & Research, Pharmaceuticals, Healthcare, Cosmetics, Beauty Supply & Personal Care Products, Consumer Goods, Manufacturing |
| Keywords | Pharmaceutical Products, Healthcare, Personal Care, Specialty Chemicals, Research, Development, Consumer Goods, Drug Development, Manufacturing, Cosmetics, Beauty Products, Supply Chain, Quality Control, Regulatory Affairs, Skincare, Ingredients, Distribution, Haircare, Clinical Trials |
| Competitors | Takeda, Baxter International Inc., Fresenius Kabi, Catalent Pharma Solutions, Grifols, Eisai Co., Ltd., CSL Behring, Octapharma, Kedrion Biopharma, US Biotest +45 more (view full list) |
| SIC | SIC Code 284 Companies, SIC Code 28 Companies, SIC Code 2844 Companies |
| NAICS | NAICS Code 32541 Companies, NAICS Code 325 Companies, NAICS Code 32 Companies, NAICS Code 3254 Companies |
Looking for a particular CCS employee's phone or email?
The CCS annual revenue was $360.9 million in 2026.
Andrea Venezia is the Senior Vice President of CCS.
30 people are employed at CCS.
The NAICS codes for CCS are [32541, 325, 32, 3254].
The SIC codes for CCS are [284, 28, 2844].